Empiric Treatment of Localized Infections in the Febrile Neutropenic Patient with Monotherapy

References

• Raber-Durlacher J. E., Abraham-Inpijn L., Van Leeuwen E. F., Lustig K. H. M.E., Van Winkelhof A. J. The prevention of oral complications in bone marrow transplantations by means of oral hygeine and dental intervention. Neth. J. Med. 1989; 34: 98–108
   PubMed Web of Science ®Google Scholar
• Raemaekers J., De Witte T., Schattenberg A., Van Der Lely N. Prevention of leukemic relapse after transplantation with lymphocyte-depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines. Bone Marrow Trans. 1989; 4: 167–171
   PubMed Web of Science ®Google Scholar
• Scarffe J. H. Emerging Clinical Uses for GM-CSF. Eur. J. Cancer 1991; 27(11)1493–1504
   PubMed Web of Science ®Google Scholar
• Bone R. C., Fisher C. J., Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A., The Methylprednisolone Sever Sepsis Study Group. Sepsis syndrome: a valid clinical entity. Critical Care Med. 1989; 17: 389–393
   PubMed Web of Science ®Google Scholar
• Ligtenberg P. C., Hoepelman I. M., Oude Sogtoen G. A. C., Dekker A. W., van der Twee L. I., Rozenberg-Arska M., Verhoef J. C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients. Eur. J. Clin. Microbiol. and Infect. Dis. 1991; 10(1)25–31
   PubMed Web of Science ®Google Scholar
• De Bel C., Gerritsen E., De Maaker G., Moolenaar A., Vossen J. C- reactive protein in the management of children with fever after allogeneic bone marrow transplantation. Infection 1991; 19(2)92–96
   PubMed Web of Science ®Google Scholar
• Donowitz G. R., Harman C., Pope T., Stewart M. The role of the chest roentgenogram in febrile neutropenic patients. Arch. Int. Med. 1991; 151: 701–704
   PubMed Web of Science ®Google Scholar
• Brown D. F. J., Warren R. E. Effect of sample volume on yield of positive blood cultures from adult patients with haematological malignancy. J. Clin. Pathol. 1990; 43: 777–779
   PubMed Web of Science ®Google Scholar
• Kiehn T. E., Armstrong D. Changes in the spectrum of organisms causing bacteraemia and fungaemia in immun-compromised patients due to venous access devices. Eur. J. Clin. Microbiol. and Infect. Dis. 1990; 9(12)869–872
   PubMed Web of Science ®Google Scholar
• Kurrle E., Bhaduri S., Kreiger D., Gaus W., Heimpel H., Pflieger H., Arnold R., Vanek E. Risk factors for infections of the oropharynx and the respiratory tract in patients with acute leukemia. J. Infect. Dis. 1981; 144: 128–136
   PubMed Web of Science ®Google Scholar
• Schimpff S. C. An overview of empiric antibiotic therapy for the febrile neutropenic patient. Rev. Infect. Dis. 1985; 7(suppl 4)S734–740
   Google Scholar
• Hughes W. T., Armstrong D., Bodey G. P., Feld R., Mandell G. L., Meyers J. D., Pizzo P. A., Schimpff S. C., Shenep J. L., Wade J. C., Younc L. S., Yow M. D. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J. Infect. Dis. 1990; 161: 381–396
   PubMed Web of Science ®Google Scholar
• EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of Gram-negative bacteraemia in cancer patients with granulocytopenia. N. Eng. J. Med. 1987; 317: 1692–1698
   PubMed Web of Science ®Google Scholar
• Anaissie E. J., Fanstein V., Bodey G. P., Rolston K., Elting L., Kantarjian H., Cabanillas F., McCredie K. B. Randomized trials of β-lactams regimens in febrile neutropenic cancer patients. Am. J. Med. 1988; 84: 581–589
   PubMed Web of Science ®Google Scholar
• Bodey G. P., Fainstein V., Elting L. S., Anaissie E., Rolston K., Khardori N., Kantarjian H., Plager C., Murphy W. K., Holmes F., Cabanillas F. β-lactams rgimens for the febrile neutropenic patient. Cancer 1990; 65: 9–16
   PubMed Web of Science ®Google Scholar
• De Pauw B. E., Kauw F., Muytjens H., Williams K. J., Bothof T. Randmized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients. J. Antimicrob. Chemother. 1983; 12(Suppl A)93–99
   PubMedGoogle Scholar
• De Pauw B. E., Williams K. J., De Neeff J., Bothoff T., De Witte T., Holdrinet R., Haanen C. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacinillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob. Ag. Chemother 1985; 28: 824–828
   PubMed Web of Science ®Google Scholar
• Donnelly J. P., Worsley A. M., Marcus R. E., Goldman J. M., Cohen J., Worsley A. M., Catovsky D., Darrell J. H., Want S. V., Galton D. A. G. Ceftazidime as first-line therapy for the treatment of fever in acute leukemia. J. Infect. 1985; 11: 205–215
   PubMed Web of Science ®Google Scholar
• Nováková I. R. O., Donnelly J. P., De Pauw B. E. Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteraemia in febrile granulocytopenic patients. Antimicrob. Ag. Chemother. 1991; 35: 672–678
   PubMed Web of Science ®Google Scholar
• Nováková I. R. O., Donnelly J. P., De Pauw B. E. Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile granulocytopenic patients. Ann. Hematol. 1991; 63: 195–200
   PubMed Web of Science ®Google Scholar
• Nováková I. R. O., Donnelly J. P., De Pauw B. E. Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteraemia. Scan. J. Infect. Dis. 1990; 22: 705–711
   PubMed Web of Science ®Google Scholar
• Pizzo P. A., Hathorn J. W., Hiemenz J., Browne M., Commers J., Cotton D., Gress J., Longo D. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N. Eng. J. Med. 1986; 315: 552–558
   PubMed Web of Science ®Google Scholar
• Verhagen C. S., De Pauw B. E., De Witte T., Janssen J., Williams K. J., De Mulder P., Bothof T. Randomized prospective study of ceftazidime versus ceftazi-dime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob. Ag. Chemother. 1987; 31: 191–196
   PubMed Web of Science ®Google Scholar
• Sanders J. W., Powe N. R., Moore R. D. Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients-A metaanalysis. J. Infect. Dis. 1991; 164(5)907–916
   PubMed Web of Science ®Google Scholar
• Liang R., Yung R., Chau C. E. P., Chan T., Lam W., Todd D. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients. Antimicrob. Ag. Chemother. 1990; 34: 1336–1341
   PubMed Web of Science ®Google Scholar
• Winston D. J., Ho W. G., Bruckner D. A., Champlin R. E. Beta-lactam antibiotic therapy in febrile granulocyto-penic patients-A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin and imipenem alone. Ann. Int. Med. 1991; 115(11)849–859
   PubMed Web of Science ®Google Scholar
• Rolston K. V. I., Berkey P., Bodey G. P., Anaissie E. J., Khardori N., Joshi J. H., Keating M. J., Holmes F. A., Cabanillas F. F., Elting L. A comparison of imipenem to ceftazidime with and without amikacin as empiric therapy in febrile neutropenic patients. Arch. Int. Med. 1992; 152: 283–291
   PubMed Web of Science ®Google Scholar
• Bayston K. F., Want S., Cohen J. A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. Am. J. Med. 1989; 87(suppl 5A)269S–273S
   Google Scholar
• Johnson P. R. E., Liu Yin J. A., Tooth J. A. High dose intravenous ciprofloxacin in febrile neutropenic patients. J. Antimicrob. Chemother. 1990; 26(suppl F)101–107
   PubMed Web of Science ®Google Scholar
• Meunier F., Zinner S. H., Gaya H., Calandra T., Viscoli C., Klatersky J., Glauser M. Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with Lymphomas and Solid Tumors. Antimicrob. Ag. Chemother. 1991; 35(5)873–878
   PubMed Web of Science ®Google Scholar
• Malik I. A., Abbas Z., Karim M. Randomized comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients. Lancet 1992; 339: 1092–1096
   PubMed Web of Science ®Google Scholar
• Verhagen C., De Pauw B. E., Donnelly J. P., Williams K. J., De Witte T., Janssen J. T. P. Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients. J. Infect. 1986; 13: 125–131
   PubMed Web of Science ®Google Scholar
• Burden A. D., Oppenheim B. A., Crowther D., Howell A., Morgenstern G. R., Scarffe J. H., Thatcher N. Viridans Streptococcal bacteraemia in patients with haematolo-gical and solid malignancies. Eur. J. Cancer 1991; 27(4)409–411
   PubMed Web of Science ®Google Scholar
• Van der Lelie H., Van Ketel R. J., Von dem Borne A. E. G. K., Van Oers R. H. J., Thomas B. L. M., Goudsmit R. Incidence and clinical epidemiology of streptococcal septicemia during treatment of acute myeloid leukemia. Scan. J. Infect. Dis. 1991; 23(2)163–168
   PubMed Web of Science ®Google Scholar
• Elliot C. R., Pater J. L. The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients. Clin. Invest. Med. 1988; 11: 327–330
   PubMed Web of Science ®Google Scholar
• Donnelly J. P. Assessment and reporting of clinical trials of empirical therapy in neutropenic patients. J. Antimicrob. Chemother. 1991; 27: 377–387
   PubMed Web of Science ®Google Scholar
• Rubin M., Hathorn J. W., Marshall D., Gress J., Steinberg S. M., Pizzo P. A. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann. Int. Med. 1988; 108: 30–35
   PubMed Web of Science ®Google Scholar
• Awidi A. S. Infections in adults with cancer in a developing country: a three year prospective study. Eur. J. Cancer 1991; 27(4)423–426
   PubMed Web of Science ®Google Scholar
• Pizzo P. A. After empiric therapy: what to do until the granulocyte comes back. Rev. Infect. Dis. 1987; 9: 214–219
   PubMedGoogle Scholar
• Calandra T. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients-From the EORTC and National Cancer Institute of Canada. J. Infect. Dis. 1991; 163(5)951–958
   PubMed Web of Science ®Google Scholar
• De Pauw B. E., Donnelly J. P., Elves A., Verhagen C., Nováková I. R. O., Van Der Meer J. W. M. Towards individually tailored empiric antibiotic therapy in febrile granulocytopenic patients. Neth. J. Med. 1990; 37: 111–119
   PubMed Web of Science ®Google Scholar
• Walsh T. J., Pizzo P. A. Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Ann. Rev. Microbiol. 1988; 42: 517–545
   PubMed Web of Science ®Google Scholar
• Ognibene F. P., Martin S. E., Parker M. M., Schlessinger T., Roach P., Burch C., Shelhamer J. H., Parrillo J. E. Adult respiratory distress syndrome in patients with severe neutropenia. N. Eng. J. Med. 1986; 315: 547–551
   PubMed Web of Science ®Google Scholar
• Kern W., Kurrle E., Vanek E. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. Klin. Wochenschr. 1987; 65: 773–780
   PubMedGoogle Scholar
• Arning M., Gehrt A., Aul C., Runde V., Hadding U., Schneider W. Septicemia due to Streptococcus mitis in neutropenic patients with acute leukemia. Blut 1990; 61: 364–368
   PubMedGoogle Scholar
• Meyer R. D. Role of the quinolones in the treatment of legionellosis. J. Antimicrob. Chemother. 1991; 28: 623–625
   PubMed Web of Science ®Google Scholar
• Meunier F., Aoun M., Gerard M. Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs ketocona-zole. Rev. Infect. Dis. 1990; 12(suppl 3)S364–S368
   PubMedGoogle Scholar
• Bergman O. J., Mogensen S. C., Ellegaard J. Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies. Eur. J. Clin. Microbiol. and Infect. Dis. 1990; 9: 184–190
   PubMed Web of Science ®Google Scholar
• Ringdén O., Heimdahl A., Lönnequist B., Malmborg A. S., Wilczek H. Decreased incidence of viridens streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir. Lancet 1984; i: 744
   Google Scholar
• Talbot G. H., Huang A., Provencher M. Invasive aspergillus rhinosinusitis in patients with acute leukemia. Rev. Infect. Dis. 1991; 13: 219–232
   PubMedGoogle Scholar
• Denning D. W., Stevens D. A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 1990; 12: 1147–1201
   PubMedGoogle Scholar
• Weightman N. C., Simpson E. M., Speller D. C. E., Mott M. G., Oakhill A. Bacteraemia related to indwelling central venous catheters: prevention, diagnosis and treatment. Eur. J. Clin. Microbioi. and Infect. Dis. 1988; 7: 125–129
   PubMed Web of Science ®Google Scholar
• Hedin G., Hambraeus A. Multiple antibiotic-resistant Staphylococcus epidermidis in patients, staff and environment-a one-week survey in a bone marrow transplant unit. J. Hosp. Infect. 1991; 17: 95–106
   PubMed Web of Science ®Google Scholar
• De Pauw B. E., Nováková I. R. O., Donnelly J. P. Options and limitations of teicoplanin in febrile granulocytopenic patients. Brit. J. Haematol. 1990; 76(suppl 2)1–5
   PubMed Web of Science ®Google Scholar
• Nováková I. R. O., Donnelly J. P., De Pauw B. E., Verhagen C. Teicoplanin for modification of empirical treatment in neutropenic patients. J. Antimicrob. Chemother. 1990; 25: 985–993
   PubMed Web of Science ®Google Scholar
• Grant A. C., Lacey R., Brownjohn A. M., Turney J. H. Teicoplanin-resistant coagulase-negative staphylococcus. Lancet 1986; ii(letter)1166–1167
   Google Scholar
• Schwalbe R. S., Stapleton J. T., Gilligan P. H. Emergence of vancomycin resistance in coagulase negative staphylococci. N. Eng. J. Med. 1987; 316: 927–931
   PubMed Web of Science ®Google Scholar
• Wilson A. P. R., O'Hare M. D., Felmington D., Gruneberg R. N. Teicoplanin-resistant coagulase-negative staphylococcus. Lancet 1986; ii(letter)973
   Google Scholar
• Brumfitt W., Hamilton-Miller J. M. T., Neville L. O. Teicoplanin-resistant coagulase-negative staphylococci. Lancet 1987; ii(letter)328
   Google Scholar
• Arioli V., Pallanza R. Teicoplanin-resistant coagulase-negative staphylococci. Lancet 1987; i(letter)39
   Google Scholar
• Shenep J., Hughes W. T., Roberson P. K., Blankenship K., Baker D., Meyer W. H., Gigliotti F., Sixbey J. W., Santana V. M., Feldman S., Lott L. Vancomycin, ticarcillin and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile neutropenic children with cancer. N. Eng. J. Med. 1988; 319: 1053–1058
   PubMed Web of Science ®Google Scholar
• Anaissie E., Bodey G. P., Kantarjian H., David C., Barnett K., Bow E., Defelice R., Downs N., File T., Karam G., Potts D., Shelton M., Sugar A. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin-B therapy. Am. J. Med. 1991; 91(2)142–150
   PubMed Web of Science ®Google Scholar
• Thaler M., Pastakia B., Shawker T. H., O'Leary T., Pizzo P. A. Hepatic candidiasis in cancer patients. The evolving picture of the syndrome. Ann. Int. Med. 1988; 108: 88–100
   PubMed Web of Science ®Google Scholar
• Kauffman C. A., Bradley S. F., Ross S. C., Weber D. R. Hepatosplenic candidiasis-successful treatment with fluconazole. Am. J. Med. 1991; 91(2)137–141
   PubMed Web of Science ®Google Scholar
• Propst T., Vogel W., Propst A., Dietze O., Braunsteiner H. Successful treatment of recurrent hepatic candida infection with fluconazole after chemotherapy for acute leukemia-A case report. Clin. Invest. 1992; 70(1)55–58
   PubMedGoogle Scholar
• Warren R. E., Wimperis J. Z., Baglin T. P., Constantine C. E., Marcus R. Prevention of infection by ciprofloxacin in neutropenia. J. Antimicrob. Chemother. 1990; 26(suppl F)109–123
   PubMedGoogle Scholar
• Whimbey E., Kiehn T. E., Brannon P., Blevins A., Armstrong D. Bacteraemia and fungemia in patients with neoplastic disease. Am. J. Med. 1987; 82: 723–730
   PubMed Web of Science ®Google Scholar
• O'Hanley P., Easaw J., Rugo H., Easaw S. Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital. Am. J. Med. 1989; 87: 605–613
   PubMed Web of Science ®Google Scholar